Imricor Medical Systems, Inc. (IMR.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:44PM AEDT
| Previous close | 0.5300 |
| Open | 0.5200 |
| Bid | 0.5100 x N/A |
| Ask | 0.5200 x N/A |
| Day's range | 0.5200 - 0.5200 |
| 52-week range | 0.4100 - 0.6550 |
| Volume | |
| Avg. volume | 172,873 |
| Market cap | 143.193M |
| Beta (5Y monthly) | 0.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1600 |
| Earnings date | 27 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.92 |
Business WireImricor’s VISABL-AFL Trial for US FDA Approval Commences at Cardiovascular Institute of South Paris
MINNEAPOLIS, June 25, 2024--Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in real-time iCMR cardiac ablation products, is pleased to announce that the Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter (VISABL-AFL) IDE clinical trial, commenced with two procedures performed at the Cardiovascular Institute of South Paris (ICPS) (https://icps.fr).
Simply Wall St.Imricor Medical Systems Full Year 2023 Earnings: US$0.14 loss per share (vs US$0.12 loss in FY 2022)
Imricor Medical Systems ( ASX:IMR ) Full Year 2023 Results Key Financial Results Net loss: US$22.6m (loss widened by...
© 2024 Yahoo. All rights reserved.